PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'São Paulo State Univ UNESP, Botucatu Medical School, Blood Transfusion Center, Cell Engineering Lab, Botucatu, SP, Brazil. Electronic address: e.deffune@unesp.br.\', \'São Paulo State Univ UNESP, Botucatu Medical School, Blood Transfusion Center, Cell Engineering Lab, Botucatu, SP, Brazil.\', \'São Paulo State Univ UNESP, Botucatu Medical School, Blood Transfusion Center, Cell Engineering Lab, Botucatu, SP, Brazil; São Paulo State Univ UNESP, Araraquara School of Pharmaceutical Sciences, Department of Clinical Analysis Laboratory of Monoclonal Antibodies, Araraquara, SP, Brazil.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0306-9877(20)30552-110.1016/j.mehy.2020.109769
?:hasPublicationType
?:journal
  • Medical hypotheses
is ?:pmid of
?:pmid
?:pmid
  • 32371362
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.443
?:rankingScore_hIndex
  • 75
is ?:relation_isRelatedTo_publication of
?:title
  • Mesenchymal stem cell (MSc) secretome: A possible therapeutic strategy for intensive-care COVID-19 patients.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all